Rankings · Dividends
A-graded dividend payers
Graded A and paying a regular dividend yielding at least 1%, ranked by size rather than by yield. The highest yields usually belong to the companies under the most strain, so a list opening on them would mislead.
15 companies meet this test
Figures as of October 1, 2026
| # | Company | Grade | Market value | Dividend yield | Years of rises | Payout ratio |
|---|---|---|---|---|---|---|
| 1 | JNJJohnson & Johnson | A+ | $644.8B | 2.0% | 9+ years | 61% |
| 2 | MRKMerck & Co., Inc. | A | $368.3B | 2.3% | 9+ years | 267% |
| 3 | NVSNovartis AG | A | $278B | 2.1% | 6 years | 43% |
| 4 | AZNASTRAZENECA PLC | A+ | $256.5B | 2.0% | 2 years | 49% |
| 5 | AMGNAmgen Inc. | A+ | $229B | 2.3% | 9+ years | 62% |
| 6 | GILDGILEAD SCIENCES, INC. | A | $187.6B | 2.1% | 9+ years | — |
| 7 | MDTMedtronic plc | A+ | $111.4B | 2.7% | 1 year | 57% |
| 8 | SYKSTRYKER CORP | A+ | $107B | 1.2% | 6 years | 36% |
| 9 | GSKGSK plc | A+ | $106.5B | 3.6% | 2 years | 48% |
| 10 | ZTSZoetis Inc. | A+ | $29B | 3.0% | 9+ years | 34% |
| 11 | ZBHZIMMER BIOMET HOLDINGS, INC. | A | $17.4B | 1.1% | 0 years | 23% |
| 12 | SNNSmith & Nephew plc | A | $11.8B | 2.8% | 1 year | 53% |
| 13 | ATRAptarGroup, Inc | A | $7.8B | 1.6% | 9+ years | 35% |
| 14 | GRFSGrifols SA | A | $5B | 3.1% | 0 years | 87% |
| 15 | USPHU S PHYSICAL THERAPY INC /NV | A | $1.3B | 2.1% | 5 years | 137% |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.